IFNA1 and sarcoidosis: The spectrum of pulmonary toxicity associated with the use of IFN-α is diverse with commonly reported pulmonary toxicities being interstitial pneumonitis and sarcoidosis-like lesions followed by few case reports of pleural effusion, exacerbation of asthma, and secondary organizing pneumonia [4, 12].